218 related articles for article (PubMed ID: 3710421)
1. Effects of human growth hormone administration on growth rate and growth-stimulating activity of serum, measured by lymphocyte bioassay in hypopituitary children.
Bozzola M; Lorini R; Schimpff RM; Severi F; Job JC
Horm Metab Res; 1986 Apr; 18(4):264-7. PubMed ID: 3710421
[TBL] [Abstract][Full Text] [Related]
2. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
[TBL] [Abstract][Full Text] [Related]
3. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
Kastrup KW; Andersen H; Eskildsen PC; Jacobsen BB; Krabbe S; Petersen KE
Acta Paediatr Scand Suppl; 1979; 277():8-13. PubMed ID: 396757
[TBL] [Abstract][Full Text] [Related]
4. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
5. Somatomedin, transferrin and amino-acids in serum following injection of human growth hormone in children with growth disease.
Repellin AM; Schimpff RM; Georges P; Job JC
Horm Metab Res; 1984 Oct; 16(10):539-43. PubMed ID: 6500489
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha levels in children with growth hormone deficiency and the effect of long-term growth hormone replacement therapy.
Andiran N; Yordam N
Growth Horm IGF Res; 2007 Apr; 17(2):149-53. PubMed ID: 17314057
[TBL] [Abstract][Full Text] [Related]
7. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone treatment for short stature.
Van Vliet G; Styne DM; Kaplan SL; Grumbach MM
N Engl J Med; 1983 Oct; 309(17):1016-22. PubMed ID: 6684729
[TBL] [Abstract][Full Text] [Related]
9. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
Schmitt K; Schober E; Birnbacher R; Frisch H
Klin Padiatr; 1996; 208(1):29-34. PubMed ID: 8851324
[TBL] [Abstract][Full Text] [Related]
10. [Stimulating action of human serum on the incorporation of tritiated thymidine in human lymphocytes activated by lectins: demonstration of the GH-dependency and its limitations].
Schimpff RM; Bozzola M
C R Acad Sci III; 1984; 299(7):235-7. PubMed ID: 6435820
[TBL] [Abstract][Full Text] [Related]
11. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
12. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
[TBL] [Abstract][Full Text] [Related]
13. High serum sex hormone-binding globulin (SHBG) and low serum non-SHBG-bound testosterone in boys with idiopathic hypopituitarism: effect of recombinant human growth hormone treatment.
Belgorosky A; Martinez A; Domene H; Heinrich JJ; Bergada C; Rivarola MA
J Clin Endocrinol Metab; 1987 Dec; 65(6):1107-11. PubMed ID: 3680477
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
Blethen SL; Daughaday WH; Weldon VV
J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
[TBL] [Abstract][Full Text] [Related]
15. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
Huseman CA; Hassing JM
J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
[TBL] [Abstract][Full Text] [Related]
16. Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarism.
Grunt JA; Howard CP; Daughaday WH
Acta Endocrinol (Copenh); 1984 Jun; 106(2):168-74. PubMed ID: 6539552
[TBL] [Abstract][Full Text] [Related]
17. Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children.
Tanner JM; Whitehouse RH; Hughes PC; Carter BS
J Pediatr; 1976 Dec; 89(6):1000-8. PubMed ID: 993900
[TBL] [Abstract][Full Text] [Related]
18. Endogenous dopaminergic dysfunction: a novel form of human growth hormone deficiency and short stature.
Huseman CA; Hassing JM; Sibilia MG
J Clin Endocrinol Metab; 1986 Mar; 62(3):484-90. PubMed ID: 3080463
[TBL] [Abstract][Full Text] [Related]
19. Urinary human growth hormone measurement using a highly sensitive sandwich enzyme immunoassay: diagnostic and therapeutic uses in patients with growth hormone deficiency.
Kohno H; Murakami Y; Kodaira T
J Clin Endocrinol Metab; 1990 Dec; 71(6):1496-500. PubMed ID: 2229307
[TBL] [Abstract][Full Text] [Related]
20. Bioassay of growth-stimulating activity of serum: comparison of lymphocyte and cartilage assays in normal and growth hormone-deficient children.
Bozzola M; Schimpff RM; Charrier J; Severi F; Job JC
Horm Res; 1985; 21(2):102-6. PubMed ID: 3979947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
